First Class Metals (FCM) the UK metals exploration company seeking economic metal discoveries across its extensive Canadian Schreiber-Hemlo, Sunbeam and Zigzag land holdings, announced the launch of a systematic exploration campaign
First Class Metals (FCM) the UK metals exploration company seeking economic metal discoveries across its extensive Canadian Schreiber-Hemlo, Sunbeam and Zigzag land holdings, announced the launch of a systematic exploration campaign
By the end of the week, the AIM All-Share had balanced out at 746.42. This was notably lower than the FTSE 100, which increased by over 3%.
Poolbeg Pharma (POLB), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announced its unaudited interim results for the six months to 30 June 2023.
CleanTech Lithium (CTL), a sustainable lithium explorer and developer in Chile, announced that the company’s subsidiaries in Chile, Atacama Salt Lakes SpA and Laguna Negro Francisco SpA.
There was not much good news on either the political or economic front this week, with perhaps the saving grace being that many stock market participants have decided that hiding
Reabold Resources (RBD), the oil & gas investing company, provided an update on developments in the approvals process for the onshore Colle Santo gas field in Abruzzo, Italy.
Arrow Exploration (AXL), the operator with a portfolio of assets across key Colombian hydrocarbon basins, provided an update on the operational activity at the Carrizales Norte field on the Tapir
Hummingbird (HUM) provided a Group operational and trading update for the second quarter of 2023, ending June 30 2023.
The AIM All-Share Index dropped 1.8% to 740 this week, effectively reflecting the previous week’s poor performance.
Streaks Gaming (STK), a UK-based provider of AI focused conversational gaming “Streaks Gaming”, announced its audited results for the 12 months ended 28 February 2023.
While it is quiet over the weekend for other news platforms. Share Talk has conducted a webinar with an Oil major in the US, due for release next week, RNS